Table 4 Baseline characteristics of all ECMO-treated ARDS patients according to survival status 6 months post-ICU discharge
Characteristic | All patients (n = 51) | Status 6 months post-ICU | Pvalue | |
|---|---|---|---|---|
Alive (n = 28) | Dead (n = 23) | |||
Age (years) | 48 (33-58) | 42 (31-53) | 56 (38-60) | 0.05 |
Men | 27 (53) | 16 (57) | 11 (48) | 0.35 |
Body mass index (kg/m2) | 25 (22-29) | 26 (23-29) | 24 (20-32) | 0.36 |
Charlson score | 2 (1-4) | 1 (1-4) | 4 (2-5) | 0.03 |
SAPS II | 48 (30-61) | 43 (29-56) | 51 (39-67) | 0.09 |
SOFA score | 12 (9-13) | 11 (9-13) | 12 (9-15) | 0.09 |
Chronic lung disease | 8 (16) | 4 (14) | 4 (17) | 0.76 |
Pregnant or postpartum | 0 (0) | 0 (0) | 0 (0) | 1.0 |
Diabetes mellitus | 7 (14) | 3 (11) | 4 (17) | 0.69 |
Renal insufficiency | 4 (8) | 3 (11) | 1 (4) | 0.62 |
Immunocompromiseda | 17 (33) | 7 (25) | 10 (44) | 0.23 |
Hematological malignancies | 4 (8) | 3 (11) | 1 (4) | 0.32 |
Solid tumor | 4 (8) | 1 (4) | 3 (13) | 0.32 |
Solid organ transplantation | 3 (6) | 2 (7) | 1 (4) | 0.67 |
High-dose or long-term CS/IS | 9 (18) | 4 (14) | 5 (22) | 0.49 |
HIV | 3 (6) | 2 (7) | 1 (4) | 0.67 |
ARDS etiology | 0.27 | |||
Peri-/postoperative | 5 (10) | 3 (11) | 2 (9) | |
Influenza A H1N1 | 8 (16) | 2 (7) | 6 (26) | |
Influenza other | 7 (14) | 3 (11) | 4 (17) | |
Bacterial infection | 21 (41) | 13 (47) | 8 (35) | |
Primary ARDS | 8 (16) | 5 (18) | 3 (13) | |
Others | 3 (6) | 2 (7) | 1 (4) | |